Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense

PLoS Pathog. 2022 Feb 9;18(2):e1009986. doi: 10.1371/journal.ppat.1009986. eCollection 2022 Feb.

Abstract

The Nrf2/Keap1 axis plays a complex role in viral susceptibility, virus-associated inflammation and immune regulation in host cells. However, whether or how the Nrf2/Keap1 axis is involved in the interactions between equine lentiviruses and their hosts remains unclear. Here, we demonstrate that the Nrf2/Keap1 axis was activated during EIAV infection. Mechanistically, EIAV-Rev competitively binds to Keap1 and releases Nrf2 from Keap1-mediated repression, leading to the accumulation of Nrf2 in the nucleus and promoting Nrf2 responsive genes transcription. Subsequently, we demonstrated that the Nrf2/Keap1 axis represses EIAV replication via two independent molecular mechanisms: directly increasing antioxidant enzymes to promote effective cellular resistance against EIAV infection, and repression of Rev-mediated RNA transport through direct interaction between Keap1 and Rev. Together, these data suggest that activation of the Nrf2/Keap1 axis mediates a passive defensive response to combat EIAV infection. The Nrf2/Keap1 axis could be a potential target for developing strategies for combating EIAV infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants / metabolism
  • Antiviral Agents / pharmacology*
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Gene Products, rev / metabolism*
  • Humans
  • Infectious Anemia Virus, Equine / metabolism*
  • Kelch-Like ECH-Associated Protein 1 / metabolism*
  • NF-E2-Related Factor 2 / metabolism
  • Oxidative Stress / drug effects
  • Signal Transduction / drug effects

Substances

  • Antioxidants
  • Antiviral Agents
  • Gene Products, rev
  • KEAP1 protein, human
  • Kelch-Like ECH-Associated Protein 1
  • NF-E2-Related Factor 2

Grants and funding

This study was supported by grants from the National Natural Science Foundation of China (31672533 to Y L, 31302066 to X-F W, 31970161 to L N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.